|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn747412092 |
003 |
OCoLC |
005 |
20231117044619.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
110729s2011 ne a ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d YDXCP
|d OPELS
|d OCLCQ
|d OCLCF
|d OCLCQ
|d N$T
|d OCLCQ
|d DEBBG
|d D6H
|d LEAUB
|d OL$
|d UKBTH
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 742589978
|
020 |
|
|
|a 9780123812919
|q (electronic bk.)
|
020 |
|
|
|a 0123812917
|q (electronic bk.)
|
020 |
|
|
|a 9780123812902
|q (electronic bk.)
|
020 |
|
|
|a 0123812909
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)747412092
|z (OCoLC)742589978
|
050 |
|
4 |
|a RS403
|b .P76 2011eb
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
082 |
0 |
4 |
|a 615.1/9
|2 23
|
245 |
0 |
0 |
|a Progress in medicinal chemistry 50 /
|c editors, G. Lawton and D.R. Witty.
|
246 |
3 |
|
|a Progress in medicinal chemistry.
|n Volume 50
|
250 |
|
|
|a 1st ed.
|
260 |
|
|
|a Amsterdam, the Netherlands :
|b Elsevier,
|c 2011.
|
300 |
|
|
|a 1 online resource (x, 196 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Progress in medicinal chemistry,
|x 0079-6468 ;
|v v. 50
|
504 |
|
|
|a Includes bibliographical references and indexes.
|
520 |
|
|
|a Annual Review of Eclectic Developments in Medicinal Chemistry *Presents the latest research in the field of drug discovery *Publishes on a twice yearly basis to bring you the most innovative updates in medicinal chemistry *Available as an online resource via ScienceDirect.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Progress in Medicinal Chemistry 50; Copyright; Preface; Contents; List of Contributors; Chapter 1 -- Designing Drugs to Avoid Toxicity; Chapter 2 -- Prostaglandin D2 Receptor CRTH2 Antagonists for the Treatment of Inflammatory Diseases; Chapter 3 -- Progress in the Development of Small Molecule Therapeutics Targeting Th17 Cell Function for the Treatment of Immune-Inflammatory Diseases; Chapter 4 -- Therapeutic Applications of Iminosugars: Current Perspectives and Future Opportunities; Subject Index; Cumulative Index of Authors forVolumes 1-50
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
|
2 |
|a Chemistry, Pharmaceutical
|0 (DNLM)D002626
|
650 |
|
6 |
|a Chimie pharmaceutique.
|0 (CaQQLa)201-0028674
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Pharmaceutical chemistry
|2 fast
|0 (OCoLC)fst01060115
|
700 |
1 |
|
|a Lawton, G.
|
700 |
1 |
|
|a Witty, D. R.
|
776 |
0 |
8 |
|i Print version:
|t Progress in medicinal chemistry. Vol. 50.
|b 1st ed.
|d Amsterdam : Elsevier, �2010
|z 9780123812902
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780123812902
|z Texto completo
|